Is taltz effective for scalp psoriasis?

Is Taltz effective for scalp psoriasis?
Taltz (ixekizumab) reduces scalp psoriasis severity in many patients. In a 12-week study of adults with moderate to severe plaque psoriasis, scalp-specific scores dropped significantly compared with placebo.

How quickly does Taltz clear scalp lesions?
Most improvement occurs within the first four weeks, with further gains through week 12.

What happens if scalp psoriasis returns after stopping Taltz?
Relapse is common when treatment ends; many patients need ongoing therapy or re-treatment to maintain clearance.

How does Taltz compare with other scalp psoriasis options?
Compared with topical steroids or vitamin-D analogues, Taltz offers faster and more complete scalp clearance for moderate-to-severe disease. It differs from oral agents such as apremilast by working through IL-17 inhibition rather than PDE-4 blockade.

What side effects matter most for scalp use?
Injection-site reactions and upper-respiratory infections are the most frequently reported; hairline irritation is uncommon because Taltz is given systemically.

When does Taltz’s patent expire?
The primary U.S. composition-of-matter patent for ixekizumab expires in 2028, with possible extensions into the early 2030s. [1]

Can biosimilars launch before Taltz’s patent expires?
Biosimilar entry before 2028 is unlikely without successful patent challenges or settlements.

[1] DrugPatentWatch.com